FOXBusiness.com: Elan offers Tysabri dividend after Royalty approach

FOXBusiness.com FOX Business Network - The Power to Prosper

Elan offers Tysabri dividend after Royalty approach Mar 4th 2013, 08:08 Irish drugmaker Elan said it will give shareholders 20 percent of the royalty rights for multiple sclerosis drug Tysabri in a bid to stave off an approach for the company by U.S. investment firm Royalty Pharma .

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions